García, I. M., Martínez-Penella, M., Mira-Sirvent, M., Núñez-Bracamonte, S., Conesa-Nicolás, E., Viney, A., . . . Gutiérrez-Cívicos, M. (2018). 4CPS-110 Impact of patients’ conditions on the effectiveness and safety of erlotinib in pancreatic cancer. Eur J Hosp Pharm.
Παραπομπή Chicago StyleGarcía, I Muñoz, et al. "4CPS-110 Impact of Patients’ Conditions On the Effectiveness and Safety of Erlotinib in Pancreatic Cancer." Eur J Hosp Pharm 2018.
Παραπομπή MLAGarcía, I Muñoz, et al. "4CPS-110 Impact of Patients’ Conditions On the Effectiveness and Safety of Erlotinib in Pancreatic Cancer." Eur J Hosp Pharm 2018.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.